Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow-fiber infection model system.
about
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.Comparative in vitro and in vivo efficacies of human simulated doses of ceftazidime and ceftazidime-avibactam against Pseudomonas aeruginosa.Evaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model.Prediction of the pharmacodynamically linked variable of oseltamivir carboxylate for influenza A virus using an in vitro hollow-fiber infection model system.Pharmacokinetic determinants of virological response to raltegravir in the in vitro pharmacodynamic hollow-fiber infection model system.Pharmacodynamic analysis of a serine protease inhibitor, MK-4519, against hepatitis C virus using a novel in vitro pharmacodynamic system.
P2860
Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow-fiber infection model system.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Pharmacodynamics of cidofovir ...... -fiber infection model system.
@en
Pharmacodynamics of cidofovir ...... -fiber infection model system.
@nl
type
label
Pharmacodynamics of cidofovir ...... -fiber infection model system.
@en
Pharmacodynamics of cidofovir ...... -fiber infection model system.
@nl
prefLabel
Pharmacodynamics of cidofovir ...... -fiber infection model system.
@en
Pharmacodynamics of cidofovir ...... -fiber infection model system.
@nl
P2093
P2860
P356
P1476
Pharmacodynamics of cidofovir ...... -fiber infection model system.
@en
P2093
George L Drusano
James J McSharry
Kris Zager
Mark R Deziel
Qingmei Weng
P2860
P304
P356
10.1128/AAC.00708-08
P407
P577
2008-10-13T00:00:00Z